Prominent dominant negative effect of a mutant Fas molecule lacking death domain on cell-mediated induction of apoptosis

Molecular Immunology

Volumn 42, Issue 1, 2005, Pages 71-78

  Yokota, Aya ^a   Takeuchi, Emiko ^a   Iizuka, Misao ^a   Ikegami, Yuko ^b   Takayama, Hajime ^b   Shinohara, Nobukata ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MITSUBISHI KASEI INST OF LIFE SCI   (Japan)

Author keywords

ALPS; Death domain; DISC; Dominant negative effect; Fas

Indexed keywords

FAS ANTIBODY; FAS ANTIGEN; FAS LIGAND; MUTANT PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HETEROZYGOSITY; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PHENOTYPE; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; WILD TYPE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; CELL COMMUNICATION; CELL LINE, TUMOR; FAS LIGAND PROTEIN; GENES, DOMINANT; LYMPHOMA, B-CELL; MEMBRANE GLYCOPROTEINS; MICE; MUTATION; PHENOTYPE; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSFECTION;

MURINAE;

EID: 5444221467     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2004.07.042     Document Type: Article

References (27)

1. I. Cascino, G. Papoff, R. De Maira, R. Testi, and G. Ruberti Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis J. Immunol. 156 1996 13 17
2. R.W. Chesnut, S.M. Colon, and H.M. Grey Requirements for the processing of antigens by antigen-presenting B cells. I. Functional comparison of B cell tumors and macrophages J. Immunol. 129 1982 2382 2388
3. H. Fukuyama, M. Adachi, S. Suematsu, K. Miwa, T. Suda, N. Yoshida, and S. Nagata Transgenic expression of Fas in T cells blocks lymphoproliteration but not autoimmune disease in MRL-lpr mice J. Immunol. 160 1998 3805 3811
4. S. Hanabuchi, M. Koyanagi, A. Kawasaki, N. Shinohara, A. Matsuzawa, Y. Nishimura, Y. Kobayashi, S. Yonehara, H. Yagita, and K. Okumura Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity Proc. Natl. Aca. Sci. U.S.A. 91 1994 4930 4934
5. N. Holler, A. Tardivel, M. Kovacsovics-Bankowski, S. Hertig, O. Gaide, F. Martinon, A. Tinel, D. Deperthes, S. Calderara, T. Schulthess, J. Engel, and J. Tschopp Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex Mol. Cell. Biol. 23 2003 1428 1440
6. C.E. Jackson, R.E. Fischer, A.P. Hsu, S.M. Anderson, Y. Choi, J. Wang, J.K. Dale, T.A. Fleisher, L.A. Middelton, M.C. Sneller, M.J. Lenardo, S.E. Straus, and J.M. Puck Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance Am. J. Hum. Genet. 64 1999 1002 1014
7. H. Komano, Y. Ikegami, M. Yokoyama, R. Suzuki, S. Yonehara, Y. Yamasaki, and N. Shinohara Severe impairment of B cell function in lpr/lpr mice expressing transgenic Fas selectively on B cells Int. Immunol. 11 1999 1035 1942
8. B.L. Kotzin, S.K. Babcock, and L.R. Gerron Deletion of potentially self-reactive T cell receptor specificities in L3T4-,Lyt-2- T cells of lpr mice J. Exp. Med. 168 1988 2221 2229
9. J.D. Mountz, T.M. Smith, and K.S. Toth Altered expression of self-reactive T cell receptor Vβ regions in autoimmune mice J. Immunol. 144 1990 2159 2166
10. Y. Nishimura, A. Ishii, Y. Kobayashi, Y. Yamasaki, and S. Yonehara Expression and function of mouse Fas antigen on immature and mature T cells J. Immunol. 154 1995 4395 4403
11. D.L. Perkins, R.M. Glaser, C.A. Mahon, J. Michaelson, and A. Marshak-Rothstein Evidence for an intrinsic B cell defect in lpr/lpr mice apparent in neonatal chimeras J. Immunol. 145 1990 549 555
12. P. Schneider, N. Hollwe, J.L. Bodmer, M. Hahne, K. Fre, A. Fontana, and J. Tschopp Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity J. Exp. Med. 187 1998 1205 1213
13. R.M. Siegel, J.K. Frederiksen, D.A. Zacharias, F.K.M. Chan, M. Johnson, D. Lynch, R.Y. Tsien, and M.J. Lenardo Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations Science 288 2000 2354 2357
14. -, TCR-α/β+ and abnormal lpr and gld cell populations J. Exp. Med. 170 1989 1869 1877
15. G.G. Singer, and A.K. Abbas The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice Immunity 1 1994 365 371
16. E.S. Sobel, T. Katagiri, K. Katagiri, S.C. Morris, P.L. Cohen, and R.A. Eisenberg An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity J. Exp. Med. 173 1991 1441 1449
17. E.E. Straus, M. Sneller, M.J. Lenardo, J.M. Puck, and W. Stober An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliterative syndrome Ann. Int. Med. 130 1999 591 601
18. T. Suda, T. Okazaki, Y. Naito, T. Yokota, N. Arai, S. Ozaki, K. Nakao, and S. Nagata Expression of the Fas ligand in cells of T cell lineage J. Immunol. 154 1995 3806 3813
19. T. Suda, H. Hashimoto, M. Tanaka, T. Ochi, and S. Nagata Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing J. Exp. Med. 186 1997 2045 2050
20. H. Takayama, N. Shinohara, A. Kawasaki, Y. Someya, S. Hanaoka, H. Kojima, H. Yagita, K. Okumura, and Y. Shinkai Antigen-specific directional target cell lysis by perforin-negative T lymphocyte clones Int. Immunol. 3 1991 1149 1156
21. J.C. Unkeless Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors J. Exp. Med. 150 1979 580 596
22. A.K. Vaishnaw, J.R. Orlinick, J.L. Chu, P.H. Krammer, M.V. Chao, and K.B. Elkon The molecular basis for apoptotic defects in patients with CD95(Fas/Apo-1) mutations J. Clin. Invest. 103 1999 355 363
23. H. Walczak, and M.R. Sprick Biochemistry and function of the DISC Trends Biochem. Sci. 26 2001 452 453
24. R. Watanabe-Fukunaga, C.I. Brannan, N.G. Copeland, N.A. Jenkins, and S. Nagata Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis Nature 356 1992 314 317
25. A. Yokota, A. Oikawa, C. Matsuda, N. Shinohara, and K. Eshima Cell-mediated Fas-based lysis of dendritic cells which are apparently resistant to anti-Fas antibody Microbiol. Immunol. 47 2003 1820 1826
26. T. Zhou, H. Bluethman, J. Eldridge, M. Brockhaus, K. Berry, and J.D. Mounts Abnormal thymocyte development and production of autoreactive T cells in T cell receptor transgenic autoimmune mice J. Immunol. 147 1991 466 474
27. T. Zhou, H. Bluethmann, J. Zhang, C.K. Edwards III, and J.D. Mountz Defective maintenance of T cell tolerance to a super antigen in MRL-lpr/lpr mice J. Exp. Med. 176 1992 1063 1072